These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20636862)

  • 21. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.
    Sun D; Yu LX; Hussain MA; Wall DA; Smith RL; Amidon GL
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):75-85. PubMed ID: 14982151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new topological descriptors based model for predicting intestinal epithelial transport of drugs in Caco-2 cell culture.
    Marrero Ponce Y; Cabrera Pérez MA; Romero Zaldivar V; González Díaz H; Torrens F
    J Pharm Pharm Sci; 2004 Jun; 7(2):186-99. PubMed ID: 15367375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of complexes formation between drugs and penetration enhancers in transdermal delivery.
    Drakulić BJ; Juranić IO; Erić S; Zloh M
    Int J Pharm; 2008 Nov; 363(1-2):40-9. PubMed ID: 18675333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maximum flux versus transdermal delivery: comment on Farahmand and Maibach (2009).
    Kissel JC; Bunge AL
    Int J Pharm; 2010 Oct; 398(1-2):247-8. PubMed ID: 20600727
    [No Abstract]   [Full Text] [Related]  

  • 25. Modelling of drug disposition kinetics in in vitro intestinal absorption cell models.
    Heikkinen AT; Korjamo T; Mönkkönen J
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):180-8. PubMed ID: 20030630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evaluation of the potential of linear and nonlinear skin permeation models for the prediction of experimentally measured percutaneous drug absorption.
    Brown MB; Lau CH; Lim ST; Sun Y; Davey N; Moss GP; Yoo SH; De Muynck C
    J Pharm Pharmacol; 2012 Apr; 64(4):566-77. PubMed ID: 22420662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling the effect of mixture components on permeation through skin.
    Ghafourian T; Samaras EG; Brooks JD; Riviere JE
    Int J Pharm; 2010 Oct; 398(1-2):28-32. PubMed ID: 20643197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined multiphoton imaging-pixel analysis for semiquantitation of skin penetration of gold nanoparticles.
    Labouta HI; Kraus T; El-Khordagui LK; Schneider M
    Int J Pharm; 2011 Jul; 413(1-2):279-82. PubMed ID: 21515347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in predicting skin permeability of hydrophilic solutes.
    Chen L; Han L; Lian G
    Adv Drug Deliv Rev; 2013 Feb; 65(2):295-305. PubMed ID: 22580335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
    Ingels F; Beck B; Oth M; Augustijns P
    Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The application of feature selection to the development of Gaussian process models for percutaneous absorption.
    Lam LT; Sun Y; Davey N; Adams R; Prapopoulou M; Brown MB; Moss GP
    J Pharm Pharmacol; 2010 Jun; 62(6):738-49. PubMed ID: 20636861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A surrogate for topical delivery in human skin: silicone membranes.
    Sloan KB; Synovec J; Ketha H
    Ther Deliv; 2013 Feb; 4(2):203-24. PubMed ID: 23343160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Design of transdermal ultrasonophoresis equipment].
    Li L; Zhang Y; Li Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Feb; 26(1):184-6. PubMed ID: 19334582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
    Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
    Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical penetration enhancers.
    Newton SJ
    Int J Pharm Compd; 2013; 17(5):370-4. PubMed ID: 24459781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomes and skin: from drug delivery to model membranes.
    El Maghraby GM; Barry BW; Williams AC
    Eur J Pharm Sci; 2008 Aug; 34(4-5):203-22. PubMed ID: 18572392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Penetration properties and safety aspects of topically applied products.
    Fluhr J; Lademann J
    Skin Pharmacol Physiol; 2008; 21(6):293. PubMed ID: 18997482
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.
    Fossati L; Dechaume R; Hardillier E; Chevillon D; Prevost C; Bolze S; Maubon N
    Int J Pharm; 2008 Aug; 360(1-2):148-55. PubMed ID: 18539418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico prediction of membrane permeability from calculated molecular parameters.
    Refsgaard HH; Jensen BF; Brockhoff PB; Padkjaer SB; Guldbrandt M; Christensen MS
    J Med Chem; 2005 Feb; 48(3):805-11. PubMed ID: 15689164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical modification and formulation approaches to elevated drug transport across cell membranes.
    Majumdar S; Mitra AK
    Expert Opin Drug Deliv; 2006 Jul; 3(4):511-27. PubMed ID: 16822226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.